Bartolomé and colleagues [37] have recently reported that ALCAM, via its interaction with SOSTDC1 (sclerostin domain containing-1), increases the hepatic metastases from colorectal cancer. The gene discussed is SOSTDC1; the disease is colorectal cancer.